Wnts in adult brain: from synaptic plasticity to cognitive deficiencies by Carolina A. Oliva et al.
“fncel-07-00224” — 2013/12/2 — 17:23 — page 1 — #1
REVIEW ARTICLE
published: 03 December 2013
doi: 10.3389/fncel.2013.00224
Wnts in adult brain: from synaptic plasticity to cognitive
deﬁciencies
Carolina A. Oliva1,2 , JessicaY.Vargas1,2 and Nibaldo C. Inestrosa1,2*
1 Centro de Envejecimiento y Regeneración, Facultad de Ciencias Biológicas, Pontiﬁcia Universidad Católica de Chile, Santiago, Chile
2 Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontiﬁcia Universidad Católica de Chile, Santiago, Chile
Edited by:
Lavinia Alberi, University of Fribourg,
Switzerland
Reviewed by:
Urs Albrecht, University of Fribourg,
Switzerland
Kerry LeeTucker, University of
Heidelberg, Germany
*Correspondence:
Nibaldo C. Inestrosa, Centro de
Envejecimiento y Regeneración,
Facultad de Ciencias Biológicas,
Pontiﬁcia Universidad Católica de
Chile, Alameda 340, P.O. Box 114-D,
Santiago, Chile
e-mail: ninestrosa@bio.puc.cl
During development of the central nervous system the Wnt signaling pathway has been
implicated in a wide spectrum of physiological processes, including neuronal connectivity
and synapse formation.Wnt proteins and components of theWnt pathway are expressed
in the brain since early development to the adult life, however, little is known about
its role in mature synapses. Here, we review evidences indicating that Wnt proteins
participate in the remodeling of pre- and post-synaptic regions, thus modulating synaptic
function.We include themost recent data in the literature showing thatWnts are constantly
released in the brain to maintain the basal neural activity. Also, we review the evidences
that involve components of the Wnt pathway in the development of neurological and
mental disorders, including a special emphasis on in vivo studies that relate behavioral
abnormalities to deﬁciencies in Wnt signaling. Finally, we include the evidences that
support a neuroprotective role of Wnt proteins in Alzheimer’s disease. We postulate that
deregulation in Wnt signaling might have a fundamental role in the origin of neurological
diseases, by altering the synaptic function at stages where the phenotype is not yet
established but when the cognitive decline starts.
Keywords:Wnt in adult brain, neurodegenerative diseases,Wnt in circuit development,Wnt signaling pathways,
spontaneous activity, activity-dependent processes
INTRODUCTION
Among all developmental processes that involve Wnt signaling,
some of the more prominent are the primary embryo axis for-
mation, segmentation processes, and appendage patterning in
Drosophila; organogenesis from worms to mice, as well as stem
cell proliferation (Niehrs, 2010; Jackson and Eisenmann, 2012;
Wang et al., 2012; Wray and Hartmann, 2012). Wnt signaling has
been implicated in various diseases, including colon cancer and
melanoma (Polakis, 2012), and also in neurodegenerative diseases
(Inestrosa and Arenas, 2010; Berwick and Harvey, 2012), reﬂect-
ing its relevance in fundamental biological processes across species
(Clevers and Nusse, 2012). Because Wnt gene is fundamental to
determine a normal neural phenotype (McMahon and Moon,
1989b), in this review we focus on its function related to the cen-
tral nervous system (CNS), from embryonic neural development
to higher brain function in the adult brain.
TheWnt signaling comprises a complex cascade of components
that are under many regulatory steps. The Wnt proteins fam-
ily includes 19 members present in mammals. The prototypical
Wnt receptor is the seven transmembrane-receptor Frizzled (Fz;
Bhanot et al., 1996; Rulifson et al., 2000; van Amerongen et al.,
2008). There are also co-receptors been described, such as the
members of the low-density lipoprotein receptor-related protein
5/6 (LRP5/6; Tamai et al., 2000;Wehrli et al., 2000; Mao et al., 2001;
MacDonald et al., 2009), the single-pass transmembrane recep-
tors Tyr kinase-like orphan receptor (ROR), protein Tyr kinase 7
(PTK7), receptor Tyr kinase (RYK), and muscle skeletal receptor
Tyr kinase (MUSK) (Oishi et al., 2003; Lu et al., 2004; Cadigan
and Liu, 2006; Gordon and Nusse, 2006; Green et al., 2008; Jing
et al., 2009; Fradkin et al., 2010; Minami et al., 2010; Peradziryi
et al., 2012), and the co-receptors from the proteoglycan families
(Kikuchi et al., 2011). There are several regulatory steps for the
activity of these receptors. Not only they can be intracellularly
phosphorylated, but also there are several secreted antagonists
that can act extracellularly to modify their activity, like Cerberus
and Dickkopf-related protein 1 (Dkk-1) that bind LRP blocking
the interaction to Wnt/Frizzled (Mao et al., 2001); the secreted
Frizzled-related protein (sFRP) that binds directly to Wnt because
of the similarity they have with Fz (Finch et al., 1997; Rattner
et al., 1997); the Wnt inhibitory factor (WIF); Sclerostin (and its
homolog Wise; Cruciat and Niehrs, 2013), and two classes of Wnt
agonists, the R-spondin family and Norrin (Cruciat and Niehrs,
2013).
To date there is an enormous amount of information about
Wnt signaling components and how they are compromised in dif-
ferent phenotypes (Figure 1). Historically, Wnt proteins has been
classiﬁed as either canonical or non-canonical (Gordon andNusse,
2006). For instance, Wnt1, Wnt3a, Wnt7a/b, and Wnt8 are com-
mon activators of the canonical pathway, while Wnt4,Wnt5a, and
Wnt11 are mainly activators of the non-canonical pathway (Gor-
don and Nusse, 2006; MacDonald et al., 2009; Kikuchi et al., 2011).
However, this traditional differentiation seems to be not as simple
aswas initially deﬁned andmore aspects should be considered. The
fact that there are many different Wnt ligands and more than 15
different receptors and co-receptors allows enormous possibilities
of interaction. Moreover, as result of these interactions, differ-
ent intracellular cascades could be activated which makes that the
cellular response turns difﬁcult to be predicted (van Amerongen
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and Nusse, 2009). Furthermore, some evidences in the literature
suggest that the activation of canonical or non-canonical pathway
in a cell by a particular Wnt ligand may depend on the cellular
context and the speciﬁcity by whichWnt binds to the receptor and
co-receptor, and is not a property of the ligand itself (Mikels and
Nusse, 2006b; Grumolato et al., 2010). It has been shown that Wnt
ligands can also compete for the binding to speciﬁc receptors, caus-
ing the inhibition of the reciprocal signaling pathway (Grumolato
et al., 2010). Despite this, some combinations of Wnt ligand-Fz
receptor allow to predict the activation of a speciﬁc pathway. For
example, the binding of Wnt3a ligand to Fz1 receptor activates
the canonical pathway in PC12 cells (Chacon et al., 2008). Fur-
thermore, if the Fz receptor binds to the co-receptor LRP5/6, it
determines the activation of the canonical pathway, but if Fz binds
to the co-receptor ROR1/2 the non-canonical pathway is activated
instead.
CANONICAL Wnt/β-CATENIN PATHWAY
The ﬁrst Wnt signaling pathway identiﬁed was the “canonical
pathway” (Figure 1). This pathway is also called Wnt/β-catenin
pathway since the induction of some embryonic structures in
Xenopus (McMahon and Moon, 1989a) and the transformation of
mouse mammary cells (Wong et al., 1994) are strongly correlated
with the increment in β-catenin/TCF levels (Shimizu et al., 1997).
The activation of the Wnt/β-catenin pathway has been promi-
nently involved in regulating cell differentiation and proliferation
(Toledo et al., 2008; Niehrs, 2010; Wray and Hartmann, 2012)
controlling growth and cell fate speciﬁcation during development
(Cadigan and Nusse, 1997). Since deregulation of β-catenin/TCF
levels is a relevant feature of a variety of cancers (Reya and Clevers,
2005), this aspect of Wnt signaling is, to date, themost investigated
(Kim et al., 2013).
In steady-state or in the absence of Wnt stimulation, the cyto-
plasmic cellular levels of β-catenin are low since casein kinase-1α
(CK-1α) and glycogen synthase kinase-3β (GSK-3β) sequentially
phosphorylates the protein, targeting β-catenin for ubiquitination
and proteasome degradation (Aberle et al., 1997; Liu et al., 2002;
Nusse and Varmus, 2012). Instead, in the presence of Wnt ligand,
Wnt binds both Fz and LRP5/6 forming a Wnt-receptor com-
plex that recruits the protein disheveled (Dvl), which oligomerizes
in the plasma membrane making a platform for the recruitment
and allocation of the “β-catenin destruction complex” (Bilic et al.,
2007). This complex is formed by the scaffold protein Axin, GSK-
3β, CK-1α, and the tumor suppressor adenomatous polyposis
coli (APC; Cliffe et al., 2003; Schwarz-Romond et al., 2007; Gao
and Chen, 2010). Once the complex is recruited, CK-1α phos-
phorylates LRP5/6 which causes the inhibition of the “β-catenin
destruction complex” (Figure 1). As consequence of this inhibi-
tion, β-catenin is stabilized and accumulated in the cytoplasm and
can enter to the nucleus to activate the transcription of Wnt target
genes (Logan and Nusse, 2004) under the control of the TCF/LEF
transcription factors (T-cell factor, TCF /lymphoid enhancer fac-
tor, LEF; Clevers and Nusse, 2012). There are several Wnt target
genes that are activated in this process, including c-Myc, cyclin
D1, Axin2, and Ca2+-calmodulin-dependent protein kinase type
IV (CamKIV; Toledo et al., 2008; Arrazola et al., 2009; Hodar et al.,
2010; Nusse and Varmus, 2012).
β-CATENIN INDEPENDENT PATHWAY OR THE NON-CANONICAL
PATHWAY
There are at least two other pathways activated by Wnt lig-
ands which effects are independent of β-catenin. These pathways,
known as the “non-canonical pathways,” are grouped according
the Wnt receptor and co-receptors involved, and also by the intra-
cellular signal triggered: the planar cell polarity (PCP) pathway
and the Ca2+pathway (Figure 1). The Wnt/PCP pathway was
ﬁrst identiﬁed in Drosophila where it regulates tissue polarity and
cell migration during development (Adler, 2002; Veeman et al.,
2003). The Wnt/PCP pathway signals through c-Jun N-terminal
kinase (JNK) to control cell polarity, hence it is also known as the
Wnt/JNK pathway (Boutros et al., 1998; Yamanaka et al., 2002).
In this pathway, the binding of Wnt to the Fz receptor on the
membrane surface is followed by the activation of Rho and Rac
small GTPases which in turn stimulate ROCK and JNK, respec-
tively (Figure 1). The downstream effect of this pathway is the
regulation of the cytoskeletal organization, cell motility, and gene
expression by JNK-dependent transcription factors, for example
the activating transcription factor 2 (ATF2; Figure 1), with con-
comitant activation of its target genes (Simons and Mlodzik, 2008;
Kikuchi et al., 2011).
The Wnt/Ca2+ pathway is mostly a G-protein dependent
signaling pathway (Slusarski et al., 1997a; Kohn and Moon,
2005). The activation of the Wnt/Ca2+ pathway requires the
binding of Wnt to Fz on the membrane surface to stimulate
heterotrimeric G-proteins (Slusarski et al., 1997a,b), which acti-
vates, in turn, the phospholipase-C (PLC). As a result, PLC
in turn stimulates the generation of diacylglycerol (DG) and
inositol-1,4,5-thriphosphate [Ins(1,4,5)P3]. This last one triggers
the increase of the intracellular Ca2+-release, decreases cyclic
guanosine monophosphate (cGMP), and activates the Ca2+-
calmodulin-dependent protein kinase II (CaMKII), calcineurin,
and protein kinase-C (PKC; Veeman et al., 2003; Kohn and Moon,
2005; Montcouquiol et al., 2006). In this process several tran-
scription factors are activated, including the cAMP Response
Element-Binding Protein-1 (CREB; Figure 1).
The classiﬁcation of individual Wnt proteins in canonical and
non-canonical is used now to indicate the activation of a signal-
ing pathway, either β-catenin dependent or independent (Mikels
and Nusse, 2006a,b; van Amerongen and Nusse, 2009). It has been
shown that the induction of canonical or non-canonical pathway
depends on the particular co-receptor activated (Grumolato et al.,
2010). Moreover, the activation of a speciﬁc co-receptor by a Wnt
ligand involves a common mechanism that requires the recruit-
ment of Dvl, Axin, and GSK-3β in order to trigger either canonical
or non-canonical pathways (Grumolato et al., 2010). Strikingly,
Wnt ligands can compete for the Fz receptor at the cell surface
and cause inhibition of the reciprocal pathway (Grumolato et al.,
2010), therefore providing another control point to determine the
speciﬁcity of signaling.
Wnt EXPRESSION IN THE POSTNATAL CNS
During the establishment of neuronal connectivity at early and
late postnatal development, molecules such as the brain-derived
neurotrophic factor (BDNF),bonemorphogenetic protein (BMP),
and Wnts act in the postnatal nervous system to help the recently
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FIGURE 1 |Wnt signaling pathways and the effects in mature synapses.
(A) activation of canonical Wnt/β-catenin dependent pathway starts with the
binding ofWnt ligand to Fz receptor and to the co-receptor LRP5/6, which
induces the recruitment of Dvl and causes the inhibition of the “β-catenin
destruction complex” formed by Axin, APC, GSK3β, and CK1. The inhibition of
the “β-catenin destruction complex” causes the accumulation of β-catenin,
which is no longer phosphorylated and it translocates to the nucleus where it
activates transcription ofWnt target genes mediated byTCF/LEF. Canonical
Wnt pathway participates in synaptic plasticity and cell survival. A divergent
pathway involving proteins of the “β-catenin destruction complex”
participates in the clustering of pre-synaptic proteins and the neurotransmitter
release. TheWnt/β-catenin pathway can be blocked by Dkk-1 which binds to
LRP, or through the sFRP which binds directly toWnt ligand. (B) In the
non-canonicalWnt/JNK pathway, activation of Dvl by the binding ofWnt to Fz,
induces the activation of Rho and Rac small GTPases. Activation of Rho
signals through ROCK and the activation of Rac signals through the JNK. This
pathway is involved in the clustering of post-synaptic proteins and can also
lead gene transcription mediated by ATF2. (C) In the non-canonical Wnt/Ca2+
pathway, the binding ofWnt to Fz, activates the heterotrimeric G-proteins
which in turn signal through PLC and IP3 to induce the release of the
intracellular Ca2+ and the activation of PKC and CaMKII. In this pathway, the
transcription factor CREB is activated.Wnt/Ca2+ pathway is involved in the
clustering of post-synaptic proteins and the dendritic spine morphogenesis.
This ﬁgure is a courtesy of Felipe Serrano, Ph.D. student.
formed synapses to establish and consolidate the new cellular
interactions, and later to lead synaptic remodeling and plastic-
ity throughout life (Lu, 2003; Marques, 2005; Speese and Budnik,
2007). BDNF is not only required during early development for
neuronal survival and function (Duman and Voleti, 2012), but
also in the adult brain to improve synaptic transmission, long-
term potentiation (LTP), and ocular dominance plasticity (Magby
et al., 2006; MayaVetencourt et al., 2008; Duman andVoleti, 2012).
Recently, it has been demonstrated that BDNF is a direct target of
the canonical Wnt pathway in glial cells (Yi et al., 2012). More-
over, an activator of Wnt induces BDNF in retina glial cells and
Wnt3a induces BDNF in a retina ganglion cell line (Seitz et al.,
2010; Fragoso et al., 2011), linking both BDNF and Wnt signal-
ing pathways in common effectors actions (Yi et al., 2012). Like
BDNF,Wntproteins remain expressed in the postnatal brainwhere
they play a fundamental role modulating the connectivity between
pre- and post-synaptic regions, participating in the remodeling
of synaptic structures and regulating synaptic function (Inestrosa
and Arenas, 2010; Wisniewska, 2013). Next we brieﬂy discuss
the histological evidence that shows the expression of the Wnt
pathway in the postnatal brain (for more detail review (Oliva et al.,
2013)).
The Wnt ligands and several components of the Wnt pathway
have been identiﬁed in the adult brain in the major subdivisions
of the cerebral cortex, in the olfactory bulb (OB), and olfactory
related areas, in the hippocampal formation, neocortex, and in the
thalamus (Shimogori et al., 2004;Wayman et al., 2006; Cerpa et al.,
2008; Davis et al., 2008; Gogolla et al., 2009). In situ hybridization
shows that expression of different Wnts is particularly high in
those areas where the neurons are continuously renewed, such
as OB and DG (Shimogori et al., 2004) and during the period
of dendrite development in the hippocampus (Wayman et al.,
2006).
The presence of some components of the Wnt signaling in the
thalamus during postnatal life is also relevant (Shimogori et al.,
2004; Wisniewska, 2013), since the thalamus is the relay for most
of the sensory information to the cortex. A recent work shows
that β-catenin regulates the expression of a group of genes in the
thalamus (Wisniewska et al., 2012). These highly expressed genes
encode for proteins involved in neuronal excitability, including
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voltage-gated ion channels, neurotransmitter receptors, synap-
tic vesicle proteins, and synaptic structural proteins. As such,
they underlie cell membrane conductances of Ca2+, K+, and
Cl− ions (in the case of the GABA receptor) and directly prop-
agate, inhibit, or modify electric signals. Hence, β-catenin could
be relevant to determine the degree of excitability in the thalamic
neurons by regulating the expression of those genes and inﬂuenc-
ing the thalamocortical circuit activity (Wisniewska et al., 2012;
Wisniewska, 2013). Since sensory information is continuously
processed during the lifespan of an animal it is likely that Wnt
signaling plays an important role in thalamocortical connectiv-
ity based on experience. However, further studies are required to
address this important issue.
Whether Wnt ligands expression is crucial to determine the
ﬁnal structural and functional pattern in a mature circuit of the
adult brain is matter of speculation. However, the presence of
Wnt components in many brain areas, including those that are
actively participating in neurogenesis, or those that are implicated
in sensory processing and superior cognitive processes, suggest
that Wnt pathway is involved in more than only structural func-
tions. In the next sections we review the evidences that relate Wnt
to active structural and functional processing in mature synapses,
and we discuss the importance that this can have to modulate
active depending processes, such as synaptic plasticity.
Wnt FUNCTION IN THE DEVELOPING AND MATURE CNS
ROLE OF Wnt SIGNALING IN THE PRE-SYNAPTIC TERMINAL
Wnt ligands have been linked to the assembly of structural compo-
nents in the pre-synaptic compartments. For example,Wnt7a can
act as a retrograde signal from granular cells (GC) in the cerebel-
lum to induce pre-synaptic differentiation in themossy ﬁber (MF),
working as a synaptogenic factor (Hall et al., 2000; Ahmad-Annuar
et al., 2006). Wnt7a induces axonal spreading, increases the size of
the growth cone and its branching (Lucas and Salinas, 1997; Hall
et al., 2000) and probably contributes to the formation of the active
zones because it increases the clustering of synapsin I, a synaptic
vesicle component (Hall et al., 2000). Wnt7a also induce cluster-
ing of synaptophysin, synaptotagmin, and SV-2 without affecting
the clustering of post-synaptic proteins like the post-synaptic den-
sity protein-95 (PSD-95) (Cerpa et al., 2008). Moreover, a mutant
mouse deﬁcient in Wnt7a shows a delayed synaptic maturation
(Hall et al., 2000) supporting the notion of the ligand Wnt7a
modulating the pre-synaptic compartment. On the other hand,
lithium, a pharmacological inhibitor of GSK-3β, mimics the effect
ofWnt7aonaxonal spreading andbranching in cerebellar granular
cells in vitro, suggesting that GSK-3β also participates in synap-
tic maturation (Lucas and Salinas, 1997). However, GSK-3β is
not required for the clustering of pre-synaptic vesicle proteins
induced by Wnt7a (Cerpa et al., 2008). Instead, clustering induc-
tion correlates with β-catenin stabilization, does not involve gene
expression, and is also mimicked by Wnt3a. It has been suggested
that Wnt7a requires Dvl1 to regulate the normal recycling rate of
synaptic vesicles, and the deﬁciency of both proteins (Wnt7a/Dvl1
double null mutant mice) signiﬁcantly reduces the miniature exci-
tatory post-synaptic current (mEPSC) frequency, an indication of
a defect in the neurotransmitter release (Hall et al., 2000; Ahmad-
Annuar et al., 2006). Additionally, Wnt7a increases the frequency
of mEPSC and decreases the rate of paired-pulse facilitation (PPF)
(Cerpa et al., 2008), a protocol used to distinguish the involve-
ment of the pre-synaptic from the post-synaptic terminal (Foster
and McNaughton, 1991). Also, using FM dye it has been proved
that Wnt7a stimulates the recycling and accelerates the exocytosis
of synaptic vesicles (Hall et al., 2000; Ahmad-Annuar et al., 2006;
Cerpa et al., 2008). Wnt7b and Wnt3a also increase the number of
pre-synaptic puncta suggesting a role for these ligands in the pre-
synaptic assembly (Ahmad-Annuar et al., 2006; Cerpa et al., 2008;
Davis et al., 2008). Altogether these evidences support the role of
Wnt in the maturation and function of pre-synaptic terminals.
Wnt7a has been also involved in receptors trafﬁcking since it
increases the number and size of co-clusters of the pre-synaptic
α7-nicotinic acetylcholine receptors (α7-nAChR) and APC in
hippocampal neurons, as well as it modulates the α7-nAChR traf-
ﬁcking to the nerve terminal (Farias et al., 2007). This evidence
indicates that Wnt pathway is actively involved in the receptors
functional availability in the pre-synaptic terminal.
Most of the ligands that are able to modulate pre-synaptic dif-
ferentiation have shown to activate the Wnt/β-catenin signaling
pathway. Despite that, nanomolar concentrations of Wnt3a which
also modulates the recycling and exocytosis of synaptic vesicles
in the hippocampal synapses, increases the frequency of mEPSC
through a mechanism that involves Ca2+ entrance (Cerpa et al.,
2008; Avila et al., 2010), suggesting a cross-talk between canonical
Wnt pathway and theWnt/Ca2+ signaling (Avila et al., 2010). This
evidence implies that some of the components associated with the
non-canonical pathway may also be involved in the functional-
ity of the pre-synaptic nerve terminal. Altogether these evidences
suggest that Wnt ligands that activate canonical Wnt pathway are
involved in the pre-synaptic structure assembly and participate
during consolidation of synaptic connectivity.
ROLE OF Wnt SIGNALING IN THE POST-SYNAPTIC REGION
Wnt signaling can actively modulate the structural and func-
tional assembly of the post-synaptic terminal. For instance,
Wnt5a modulates excitatory synaptic transmission (Cerpa et al.,
2010, 2011), speciﬁcally up-regulating excitatory synaptic currents
through NMDA receptors (NMDARs), but not AMPA receptors
(AMPARs), through activation of PKC and JNK, and facilitating
the induction of excitatory LTP (Cerpa et al., 2011). Moreover,
Wnt5a actively modulates inhibitory synapses in the hippocam-
pus, increasing the turnover of GABAA receptor (GABAARs) in the
surface and increasing GABA currents by a post-synaptic mech-
anisms that involved Wnt/Ca2+/CaMKII (Cuitino et al., 2010).
Wnt5a also participates in the dendritic spine morphogenesis,
inducing de novo dendritic spines and causing an increase in
the volume and density of pre-existent spines, enhancing the
efﬁcacy of hippocampal glutamatergic synapses (Varela-Nallar
et al., 2010). Wnt5a also induces the increment of calcium in the
synaptic puncta of cultured hippocampal neurons, suggesting the
activation of Wnt/Ca2+ signaling pathway (Varela-Nallar et al.,
2010) through a mechanism that involved fast phosphorylation of
CaMKII (Farias et al., 2009). Wnt5a also modulates post-synaptic
protein assembly by increasing the clustering of PSD-95, without
affecting the total levels of this protein, via activation of Wnt/JNK
signaling pathway (Farias et al., 2009).
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Among the non-typical functions attributable to the ligands,we
consider some examples. It has been shown that Wnt3a induces
clustering of AChRs in motoneurons during the neuromuscular
innervation (Henriquez et al., 2008). This effect requires Dvl1
and agrin, a protoglycan released by motoneurons, but does not
involve Wnt/β-catenin pathway. Instead, Wnt3a induces AChRs
aggregation through activation of Rac1 (Henriquez et al., 2008).
However,Wnt3a through the activation ofWnt/β-catenin pathway
inhibits agrin-induced AChR clusters, suggesting that Wnt signal-
ing dynamically regulates the post-synaptic assembly during the
establishment of the neuromuscular junction (Wang et al., 2008).
In another example, Wnt7a has also been shown to regulate
the post-synaptic compartment by stimulating the morphogenesis
and function of excitatory dendritic spines, without affecting the
inhibitory connectivity in the hippocampus (Ciani et al., 2011).
It has been shown that Wnt7a requires Dvl expression to induce
spine growth in pre-existed post-synaptic spines, as well as the
activation of CaMKII to induce spine maturation (Ciani et al.,
2011). On the other hand, it has been shown that the ligandWnt7b
and Dvl, independently of Wnt/GSK-3β, can activate Rac and
downstream JNK to increase dendritic length and branching in
immature hippocampal neurons (Rosso et al., 2005).
Interestingly, while the activation of canonical pathway by
Wnt3a, Wnt7a, or Wnt7b induces synaptogenesis through
β-catenin stability, activation of non-canonical pathway through
Wnt5a negatively regulates synaptogenesis (Davis et al., 2008),
which could constitute a competitive mechanism to balance the
synapse formation in the brain. Altogether these evidences sup-
port the idea of a new role for traditional canonical Wnt ligands,
which associated with the non-canonical pathway may also be
involved in the functionality of the post-synaptic region.
Wnt IN NEURONAL PROCESSING
In the previous sections we mainly reviewed the role of Wnt sig-
naling pathways in synaptic structure and in particular functional
changes through development. In this section we address how
Wnt signaling may be relevant for physiological functions during
activity and non-activity dependent processes.
Wnt SIGNALING IN BASAL NEURONAL ACTIVITIES
Several evidences in the literature show that Wnt signaling is con-
stitutively released during basal synaptic activities. Using sFRP1, a
physiologicalWnt signaling inhibitor, and using a reporter cell line
that expresses GFP, it has been shown that hippocampal cultures
are spontaneously secreting measurable amounts of endogenous
Wnt (Rosso et al., 2005). Wnt is also constitutively released in
slices and speciﬁcally regulates the function of NMDAR (Cerpa
et al., 2011). Moreover, it has been shown that using PKC or JNK
inhibitors to block the downstream signaling, the basal NMDAR
synaptic neurotransmission is reduced, suggesting that Wnt is
using non-canonical components of Wnt pathway to maintain
glutamatergic neurotransmission (Cerpa et al., 2011). sFRP1 also
reduces the amplitude of evoked fEPSP in hippocampal slices,
conﬁrming that Wnt is being released to maintain the basal
tone of synaptic activity (Varela-Nallar et al., 2010). These evi-
dences strongly support the notion that during basal activity Wnt
molecules are being spontaneously released to keep functional
connectivity. Indeed, it has been observed that local inhibition
of mossy ﬁbers with sFRP decreases the levels of Wnt7a/b pro-
tein, suppressing the increased effect that an enriched ambient
has on the synapses number (Gogolla et al., 2009). Interestingly,
in animals housed in control conditions, sFRP also reduces the
synapses number, suggesting that Wnt signaling is required to
generate structural plasticity (Gogolla et al., 2009). Recently, we
identify a very dynamic effect of Wnt ligands, modulating the
spike rate in brain slices in vitro. Using a slice model in mice that
can generate spontaneous oscillations we recently demonstrated
that Wnt3a perfused into the recording solution is able to mod-
ulate the spike frequency, while antibodies against Wnt ligands
signiﬁcantly affect the oscillation (Oliva et al., 2013). The possibil-
ity that Wnt is being constantly released to exert functional effects
on the cells in a network is intriguing, as well as exciting possi-
bility. Nevertheless, the function of the released Wnts in neuronal
network remains to be resolved.
Several studies have shown that the neocortex and the hip-
pocampus are electrically active even from embryonic stages, and
this early neuronal activity has a potent trophic role, mediating
neuronal survival (Golbs et al., 2011) and maturation of molec-
ular, cellular, and structural features of cortical circuits (Owens
and Kriegstein, 2002). This spontaneous activity in the form of
spontaneous action potentials plays a fundamental role in the ﬁne
tuning of connectivity in several regions of the brain (Masland,
1977; Ben-Ari et al., 1989; Yuste et al., 1992; Feller et al., 1996;
Garaschuk et al., 1998; Komuro and Rakic, 1998; Moody and
Bosma, 2005; Mire et al., 2012). The establishment of early net-
work patterns during the ﬁrst weeks of life has different functions
and the underlying mechanisms are different of those of mature
network. The presence of molecules such as Wnt and BDNF
during particular early developmental moments may help in the
establishment and consolidation of the recently formed synapses
(Lu, 2003; Marques, 2005; Speese and Budnik, 2007), contribut-
ing to the circuitry maturation and consolidating the rhythmic
activity that can sustain adult behavior (Egorov and Draguhn,
2012). How Wnt signaling is contributing to the establishment
of mature neural circuits, is still matter of speculation, but based
on the histological and functional evidences, it is expected to be
important.
Wnt SIGNALING IN ACTIVITY-DEPENDENT PROCESSESS
Wnt ligands and receptors are expressed in areas of the brain that
undergo plasticity, suggesting that during an activity-dependent
processWnt is released to regulate synaptic transmission and ulte-
rior structural modiﬁcations. Dendritic spines, direct targets of
the Wnt action, have been considered as one of the ﬁrst visi-
ble effectors of plasticity (experience dependent)-induced changes
(Alvarez and Sabatini, 2007; Holtmaat and Svoboda, 2009; Bosch
and Hayashi, 2012). During development, synaptogenesis con-
tributes to establish the connectivity within neuronal circuits
(Holtmaat and Svoboda, 2009). Later, during postnatal devel-
opment and adolescence, activity-dependent spine maintenance
or elimination contributes to the remodeling of neuronal circuits
(Alvarez and Sabatini, 2007). In this sectionwe review the evidence
of Wnt signaling as one of the signaling pathways responsible for
structural dendritic changes during activity-dependent plasticity.
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Using high K+ solution, a solution used to mimic the depolar-
ization causedbypersistent neuronal activity (Ryan et al., 1993),Yu
and Malenka found that the increment in the number and length
of dendritic branches in culture hippocampal neurons depends
on β-catenin availability (Yu and Malenka, 2003) and showed that
this effect is reduced by Dkk-1. Using a GFP-reporter cell line to
detect Wnt they demonstrated that neuronal depolarization with
K+, increases Wnt secretion from hippocampal neurons but not
from astrocytes, contributing to the idea that changes in den-
dritic arborization depend on activity-induced Wnt release (Yu
and Malenka, 2003). Moreover, CaMKIV that has been also shown
to regulate depolarization-dependent dendritic growth requires
β-catenin (Redmond et al., 2002; Yu and Malenka, 2003).
Other evidences show that Wnt released in an activity-
dependent manner modiﬁes the structure and function of den-
dritic branches. Neuronal activity induced by high K+ sequen-
tially activates NMDARs, CaMKK, CaMKI, Ras, MEK/ERK, and
CREB-dependent transcription of Wnt2 (Wayman et al., 2006),
indicating that Wnt2 could be a CREB-responsive gene. Indeed,
Wnt2 can stimulate dendrite development by itself (Wayman et al.,
2006). Along these lines, another report showed that the Wnt
inhibitor WIF, which prevents that Wnt binds its receptor Fz (Han
and Lin, 2005), suppresses dendritic arborization induced by high
K+. Based on a previous report indicating that CaMKIV initiates
the cascade culminating in CREB activation and dendritic mat-
uration (Redmond et al., 2002), it is plausible that this effect is
mediated through CREB-dependent Wnt (Wayman et al., 2006).
This evidence strongly suggests that sustained activity can induce
synthesis of more Wnt to potentiate the cellular response. Alto-
gether, these evidences suggest an active role of Wnt in determine
the strength and remodeling of the synapse in response to an
activity-dependent process.
Using a more physiological paradigm to mimic neuronal depo-
larization, such as theta burst stimulation or high frequency
stimulation (HFS) to induce LTP (Larson et al., 1986), it has been
also shown an increases in the expression of Wnt signaling com-
ponents and the Wnt release in an activity-dependent manner.
LTP induces changes in the mRNA levels and the immunostaining
pattern of several Wnt proteins, such as Wnt3a, Fz4, β-catenin,
and Dvl3 (Chen et al., 2006). LTP also induces accumulation of
β-catenin in the nucleus and the increment of several Wnt-target
genes, conﬁrming the activation of Wnt/β-catenin/TCF pathway
by tetanic stimulation (Chen et al., 2006). In fact, the size and
number of Wnt3a puncta diminishes after tetanic stimulation,
suggesting that Wnt3a is being released in a process that depends
of NMDAR activation (Chen et al., 2006). Moreover, the treat-
ment with a speciﬁc antibody against Wnt3a shows a signiﬁcant
reduction on LTP, while incubations with lithium enhances LTP,
also showing that Wnt3a is endogenously released to activate
Wnt/β-catenin pathway (Chen et al., 2006). These studies strongly
suggest that the presence of Wnt ligand and/or the activation of
the canonical pathway are required to induce LTP.
On the other hand, a recent report has shown that neuronal
activity decreases the expression of sFRP3, releasing theWnt path-
way from its natural inhibitor (Jang et al., 2013). The reduction in
sFRP3 is essential for the activity-dependent neuronal maturation
process in the hippocampus, increasing neurogenesis (Jang et al.,
2013), a mechanism that can be used to overcome neuronal death.
This evidence suggests an important effect of neural activity on
the neurogenesis induction, process that appears to be under tight
control of Wnt signaling. More studies are required to conﬁrm
this hypothesis.
STUDYING THE FUNCTION OF Wnt SIGNALING IN VIVO
The evidences discussed here reveal that sustained depolarization
activates Wnt signaling, increases synaptic transmission and facil-
itates LTP in hippocampal brain slices and in cultured neurons.
Wnts also have a signiﬁcant effect controlling the basal activity on
brain circuits, suggesting an important role for Wnt signaling in
the regulation of spontaneous and activity-dependent plasticity
(Inestrosa and Arenas, 2010; Budnik and Salinas, 2011). However,
there is still a lack of in vivo evidence about how Wnt signaling
may affect physiological synaptic processes, for example during
active behavior.
Recent studies have suggested a role for the Wnt/β-catenin
pathway in the memory formation of adults (Maguschak and
Ressler, 2008, 2011), while, deregulation of the Wnt/β-catenin
pathway has been implicated in the Alzheimer’s diseases (ADs)
pathogenesis (Moon et al., 2004),which is associatedwithmemory
loss. However, it remains unknown how Wnt signaling is involved
in learning and memory processes in the adult. Recently, it has
been reported that stereotaxic injection of the Wnt antagonist
Dkk-1 in the basolateral amygdala interferes with the long-
termmemory consolidationwithout affecting short-termmemory
(Maguschak and Ressler, 2011). Remarkably, administration of
Wnt1 during fear memory formation also interferes with the
long-term memory consolidation in the amygdala (Maguschak
and Ressler, 2011). The Wnt1 administration avoids the transient
decrease in the Wnt1 mRNA that occurs immediately after fear
conditioning, suggesting that the rapid decrease in the expres-
sion of Wnt1 might be critical for the fear memory formation
(Maguschak and Ressler, 2011). However, not only the Wnt1
mRNA but also several genes related to Wnt signaling are rapidly
downregulated during fear learning and normalized during mem-
ory consolidation (Maguschak and Ressler, 2011). Also, during
fear memory consolidation in the amygdala there is a transient
increment of β-catenin mRNA levels, while the β-catenin dele-
tion speciﬁcally affects fear memory consolidation of adult mice
(Maguschak and Ressler, 2008).
On the other hand, a selective increment in the hippocampal
levels of Wnt7 and Wnt5a, but not Wnt3 isoform, during consoli-
dation and recall of spatial memory has been reported (Tabatadze
et al., 2012). The levels of Wnt7 in the hippocampus of animals
trained in a water maze hidden platform, are enhanced in compar-
ison to the animals trainedwith a visible platform (Tabatadze et al.,
2012). Despite in the visible platform the memory acquisition is
better, animals trained in the hidden platform have better reten-
tion memory after 30 days of training, that correlates with elevated
levels of Wnt7 (Tabatadze et al., 2012). The cells that concentrate
the expression of Wnt7 are the granular cells in the DG, showing a
correlation between the expression of Wnt7 in this region with the
establishment of the long-lasting memory (Tabatadze et al., 2012).
Recently, it has been reported that the activation of Wnt/β-
catenin pathway is also required for memory consolidation of a
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hippocampal-dependent object recognition task (Fortress et al.,
2013). Intrahippocampal administration of Dkk-1 avoids familiar
object recognition and generates a strong reduction in Wnt-
related proteins such as β-catenin, Cyclin D1, c-myc, and Wnt7,
evidencing the role of canonical Wnt signaling in hippocampal
consolidation memory (Fortress et al., 2013). In another study
it has been shown that an aged APC heterozygous knockout
(APC+/−) mice exhibit a severe insufﬁciency in the working
memory performance suggesting that a correct regulation of Wnt
signaling is determinant for the appropriate functioning of the
CNS (Koshimizu et al., 2011). More evidence has recently involved
Wnt signaling in olfactory memory in Drosophila, showing that
armadillo (homolog to β-catenin), wingless (Wnt ligand), and
arrow (co-receptor) are necessary for long term memory for-
mation (Tan et al., 2013), indicating that these mechanisms are
evolutionary conserved among spacies.
Altogether, these evidences support the idea thatWnt/β-catenin
pathway is involved in long-term memory consolidation and that
the activation of Wnt signaling in response to a sensory stimulus
induces functional long-lasting changes improving the animal’s
performance. In the next section, we review the evidences in the
literature showing that deregulation of the Wnt pathway might be
related to major neurological disorders.
Wnt SIGNALING DYSFUNCTION IN NEURODEGENERATIVE
AND MENTAL DISORDERS
During the last decades, increasing data has suggested that the
progression of a neurological disease is the result of severe neu-
roanatomical abnormalities. However, more evidences shows that
several changes in the synaptic connectivity such as the imbalance
between excitation/inhibitionmay result into a cascade of multiple
effects at the neural network levelwhich inmany cases precedes cell
degeneration or death (Hickey et al., 2008; Hermann et al., 2009;
Palop and Mucke, 2010; Penzes et al., 2013). Excitatory/inhibitory
balance critically regulates cortical network function, neural net-
work activity, and behaviors associated with psychiatric disorders
(Penzes et al., 2013). Multiple lines of evidence implicate excita-
tory and inhibitory synaptic circuits in the cortex, striatum, and
hippocampus as key cellular substrates for pathogenesis in these
disorders. In fact, major neurological diseases such as autism,
schizophrenia (SZ), bipolar disorder, and major neurodegener-
ative disorders including AD, Huntington’s disease (HD), and
Parkinson’s disease (PD) share these characteristics, that the neu-
rodegenerative diseases show progressive neuronal loss. In this
section we review the most recent studies related to the progres-
sion of the most common neurological diseases in which Wnt
signaling pathway and its components has been suggested to be
relevant (Figure 2).
ALZHEIMER’S DISEASE AND Wnt SIGNALING
Alzheimer’s disease is a neurodegenerative disorder characterized
by progressive deterioration of the individual cognitive functions,
mainly caused by synaptic damage and neuronal death in spe-
ciﬁc regions of the brain (Selkoe, 2001; Mattson, 2004; Walsh and
Selkoe,2004). Distinctive features of theADbrains are thepresence
of senile plaques, composed by extracellular deposits of amyloid-β
(Aβ) peptides and the neuroﬁbrillary tangles (NFT), composed
by intracellular aggregates of hyper-phosphorylated tau protein
(Mayeux and Stern, 2012). Despite there is not clarity yet about
the triggering factors for AD, there are some candidates which are
also common factors to several other neuronal diseases (Jope and
Johnson, 2004), among which are components of the Wnt signal-
ing machinery (Figure 2). One of them is the GSK-3β (Hooper
et al., 2008), a constitutively active protein and whose expression is
increased in the hippocampus of ADpatients (Blalock et al., 2004).
Over-expression of GSK-3β in mice prevents the induction of LTP
and reduces the spatial learning (Hernandez et al., 2002; Hooper
et al., 2007), linking the characteristic memory failure in AD to
the increment in GSK-3β. The same transgenic mouse exhibits
tau hyperphosphorylation, low β-catenin in the nucleus, and neu-
rodegeneration by NFT (Lucas et al., 2001), features that can be
prevented by chronic lithium exposure (Engel et al., 2006a,b). In
fact, GSK-3 activity mediates Aβ production from its precursor
amyloid precursor protein (APP; Phiel et al., 2003; Ryder et al.,
2003). It has been shown that GSK-3β binds presenilin-1 (PS-1),
a protein involved in the proteolytic cleavage of the APP, to pro-
duce the Aβ peptide. The expression of a mutant PS-1 shows an
increment in GSK-3 activity and in the hyperphosphorylated tau
protein in cells (Takashima et al., 1998; Zhang et al., 1998). In cul-
tured neurons the toxicity mediated by Aβ depends on increased
GSK-3β activity, but it reverses when GSK-3β expression or its
activity is blocked (Takashima et al., 1993, 1996; Busciglio et al.,
1995; Alvarez et al., 1999).
We previously demonstrated that activation of Wnt signaling
inhibits GSK-3β, and leads to neuroprotection in both hippocam-
pal cultured neurons and in vivo transgenic model of AD (Garrido
et al., 2002; Inestrosa et al., 2002; De Ferrari et al., 2003; Alvarez
et al., 2004; Quintanilla et al., 2005). A marked decrease in the
levels of β-catenin has been found in the brain of early onset
familial AD patients with PS-1 mutations (Zhang et al., 1998). It
has been shown that PS-1 form a complexwith β-catenin, similarly
to how β-catenin is associated to GSK-3 and to APC (Zhang et al.,
1998). The inhibition of the β-catenin/TCF pathway enhances the
vulnerability to apoptosis (Zhang et al., 1998), suggesting that
when β-catenin is stabilized and TCF is activated, it could lead
to neuronal survival. Moreover, Li and colleagues found that tau
hyperphosphorylation, which inhibits competitively phosphory-
lation of β-catenin by GSK-3β, protects the cells from apoptosis
(Li et al., 2007). Wnt3a can also protect from Aβ-induced apop-
tosis through binding Fz1 but no Fz2 (Chacon et al., 2008) and
the genetic variations in LRP-6 have been associated with late-
onset AD (De Ferrari et al., 2007), supporting the evidences that
alterations in Wnt/β-catenin signaling could be involved in AD.
Another molecule of the Wnt pathway involved in the AD phe-
notype is Dkk-1, that is the cross-link between the pathway to
survival/apoptosis that relate Aβ and Wnt signaling (Figure 2).
While canonical Wnt/β-catenin endorses cell survival, Aβ induces
the expression of the natural antagonist Dkk-1. In AD brains there
are an up-regulated expression of Dkk-1 compared to healthy
individuals (Caricasole et al., 2004), while the chronic overex-
pression of Dkk-1 in transgenic mice causes an age-related tau
phosphorylation and cognitive deﬁcits (Killick et al., 2012). Dur-
ing Aβ exposure there is an induction of Dkk-1 expression that
depends on p53 (Wang et al., 2000; Zhang et al., 2002; Killick et al.,
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FIGURE 2 | Major neurological disorders and their relationship with
Wnt signaling components. Summary scheme ofWnt signaling
components (in red) involved in Alzheimer disease (AD), seizure activity
(epilepsy), hippocampal sclerosis, bipolar disorder, down syndrome, and
Schizophrenia.
2012). Since Dkk-1 binds LRP5/6 to inhibit Wnt signaling, the
lack of inhibition of GSK-3β facilitates tau hyperphosphoryla-
tion and the NFT formations, leading neurotoxicity and apoptosis
causedbyAβpeptides (Caricasole et al., 2004). Dkk-1 knock-down
almost completely avoid neuronal death and tau phosphorylation,
blocking neurotoxicity induced by Aβ (Caricasole et al., 2004).
Dkk-1 can also reversibly reduce the amount of synaptic pro-
teins and the number of active pre-synaptic sites, by inducing
synaptic disassembly of both pre- and post-synaptic sites (Purro
et al., 2012). However, using an antibody anti-Dkk-1 the synaptic
loss induced by Aβ can be blocked (Purro et al., 2012). Recently
it has been reported that Dkk-1 expression increases in an age-
dependent manner and causes the reduction of hippocampal
neurogenesis. In neural progenitors with inducible loss of Dkk1
not only enhance neurogenesis and the TCF/LEF activity, but
reverses the cognitive decline related to deleterious acquisition and
memory consolidation (Seib et al., 2013). These evidences might
have several implications for future treatments of dementias and
neurodegenerative diseases, yet more studies are required.
New evidences also support a link between Aβ toxicity and
Wnt pathway. Besides APOE locus, classically associated with
susceptibility for late-onset AD, it has been identiﬁed a new sus-
ceptibility factor in late-onset AD, a loci at CLU (Lambert et al.,
2009). Both APOE and CLU,which are considered the most abun-
dant apolipoproteins in the CNS (Roheim et al., 1979), have been
involved in Aβ clearance from the brain through the blood-brain
barrier (DeMattos et al., 2004; Lambert et al., 2009). Clusterin, a
product of CLU promotes cell survival, is increased in AD models
(Killick et al., 2012) and is regulated by Wnt signaling via TCF1
(Schepeler et al., 2007). Suppression of the Wnt signaling pathway
in colon carcinoma cells lead to up-regulation of CLU (Schep-
eler et al., 2007). The knock-down of clusterin protects against Aβ
neurotoxicity and prevents the induction of Dkk-1 by Aβ (Killick
et al., 2012). In contrast, Aβ targets clusterin allowing its intracel-
lular accumulation and initiating the neurotoxicity process (Killick
et al., 2012).
The C-terminal of Dkk-1 protein, which is the domain that
antagonizes the canonical Wnt pathway through binding LRP5/6,
is responsible for the activation of gene transcription of genes
involved in AD-like pathology (Killick et al., 2012). Interestingly,
Dkk-1 blocks Wnt/β-catenin signaling and activates the non-
canonical Wnt/JNK pathway, leading the increment in c-Jun
activity (Killick et al., 2012). Thus, activation of gene transcription
in the presence of Aβ occurs due to that Dkk-1 activates Wnt/JNK
pathway, which leads to tau phosphorylation. Moreover, clusterin
and several genes from the Wnt/JNK signaling have been found in
AD human-brain (Killick et al., 2012), supporting the idea that Aβ
induces clusterin/Dkk-1/JNK pathway to produces neurotoxicity.
On the other hand, lithium an activator of Wnt/β-catenin sig-
naling (Klein and Melton, 1996; Gould et al., 2004) indirectly
induces protection against Aβ neurotoxicity in mice models of
AD (Rockenstein et al., 2007). In a study from our laboratory
we reported that in vivo activation of Wnt pathway by lithium
reduces memory loss and Aβ aggregates in APP/PS1 double trans-
genic mice, an AD animal model (Toledo and Inestrosa, 2010).
Lithium also reduces the level of tau aggregates and axonal degen-
eration in transgenic mice over-expressing human tau, suggesting
that Wnt pathway can also control tautopathy progression (Noble
et al., 2005). Moreover, lithium improves spatial memory after
being decreased by Aβ ﬁbrils injections (De Ferrari et al., 2003;
Toledo and Inestrosa, 2010) and interferes with the cleavage of
APP causing a reduction in Aβ levels (Phiel et al., 2003).
Interestingly, we observed that in vivo activation of Wnt signal-
ing also improves episodic memory of APP/PS1 mice (personal
observations). These results agree with recent ﬁndings show-
ing that the activation of Wnt/β-catenin signaling through the
inhibition of GSK-3β, can reverses the hippocampus-dependent
learning deﬁcits in a mouse model of fragile-X syndrome (Guo
et al., 2012). More studies are required, at present, to determine
the nature of this effect.
Wnt SIGNALING IN EPILEPSY AND SEIZURES
It has been described that transgenicmousewith familialmutation
associated to AD presents high levels of altered neuronal activ-
ity, indicated by the electroencephalographic studies and for the
susceptibility to develop seizure activity in several brain regions,
including neocortex and hippocampus (Palop et al., 2007). The
same incidence has been found in AD patients (Menendez, 2005).
This epileptiform activity in vivo occurs in absence of neuronal
loss, supporting the hypothesis that an aberrant neuronal activity
is a primary effect of the high Aβ levels and not a consequence of
theneurodegeneration (Palop et al., 2007; Palop andMucke,2009).
In a recent work it has been shown that the overexpression of the
APP intracellular domain (AICD) increases the susceptibility to
have spontaneous seizures, deﬁcits in LTP and seizure-induced
drugs generation (Vogt et al., 2011). Moreover, in these models the
seizure susceptibility and severity depends on the levels of AICD; at
higher AICD levels, most severe seizures (Vogt et al., 2011). These
effects are independent of the levels of Aβ, because a mice over-
expressing hAPP but with a mutation in AICD does not generates
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deﬁcits in LTP or memory, despite the levels of Aβ (Galvan et al.,
2006; Saganich et al., 2006). Both data are not contradictory and
suggest that not only high levels of Aβ but also overexpressedAICD
are required to cause seizure susceptibility. Interestingly, the over-
expression of AICD increases the levels of active GSK-3β (Ryan
and Pimplikar, 2005), something that also occur in AD patients
(Hooper et al., 2008). Whether this evidence relates Wnt signaling
with seizure susceptibility has not been demonstrated yet. How-
ever, cells with NFT inclusions and positives to active GSK-3β are
allocated in brain regions where Wnt components have been well
described (Pei et al., 1999).
On the other hand, an early expression of Dkk-1 has been found
in patients with hippocampal sclerosis, characterized by temporal
lobe epilepsy, severe neuronal loss and gliosis (Busceti et al., 2007).
Like in hypoxia/ischemia in vivo and in excitotoxicity-related neu-
ronal death in vitro (Cappuccio et al., 2005), the expression of
Dkk-1 in hippocampal sclerosis correlates with the neuronal death
(Busceti et al., 2007). In fact, the increase in Dkk-1 precedes
neuronal death in both the olfactory neurons as in the hippocam-
pus of rats that developed seizures induced by kainate (Busceti
et al., 2007). Animals previously injected with lithium are pro-
tected against neuronal loss, but not against the kainate-induced
seizures (Busceti et al., 2007). Intracerebral administrationof Dkk-
1 antisense almost completely prevents seizure-induced neuronal
death (Caricasole et al., 2004; Busceti et al., 2007), but not ictal
activity seizures (Busceti et al., 2007). These evidences suggest
that the mechanisms for neuronal loss and seizure activity are
separated, raising the possibility to use therapies targeting Wnt
signaling components to protect against the neuronal loss induced
by epilepsy.
Wnt PATHWAY IN MAJOR MENTAL DISORDERS
In the last years an increased amount of evidence has shown that
components of Wnt pathways are involved in major psychiatric
disorders. Deregulation of Wnt signaling has been implicated in
bipolar disorder (Klein and Melton, 1996; Grimes and Jope, 2001;
Gould and Manji, 2002), in autism (Moon et al., 2004; De Fer-
rari and Moon, 2006), and schizophrenia (Miyaoka et al., 1999;
Yang et al., 2003; Ftouh et al., 2005; De Ferrari and Moon, 2006;
Inestrosa et al., 2012), among others. Bipolar disorder is a mental
disorder characterized by episodes of depression interweaved by
mania (Gould and Manji, 2002) but also for other misbalances
such as sleep and circadian rhythm disturbances (Kaladchibachi
et al., 2007; Ahnaou and Drinkenburg, 2011). At the molecular
level, several evidences have converged to show that a dysregula-
tion of GSK-3β cascade is involved in bipolar disorder (Klein and
Melton, 1996; Grimes and Jope, 2001; Gould and Manji, 2002;
Valvezan and Klein, 2012). It has been shown that mice with
constitutively activated GSK-3β exhibit the same disturbances in
sleep-wake cycle, locomotor activity, and body temperature, all
major features that also can be found in bipolar patients (Tille-
man et al., 2002; Prickaerts et al., 2006; Ahnaou and Drinkenburg,
2011). Lithium has been widely used as a treatment for mood dis-
orders. Although GSK-3 seems to be the most plausible target
for lithium (Valvezan and Klein, 2012), it has not been con-
ﬁrmed yet that GSK-3 is necessary for the action of lithium,
since GSK-3 may activate several downstream mechanisms by
which exerts its effects, such as Wnt and Akt signaling pathways
(Valvezan and Klein, 2012). An evidence that link lithium effect
with Wnt signaling is the fact that lithium stimulates neuro-
genesis (Samuels and Hen, 2011). Lithium, through GSK-3β
inhibition, activates the canonical Wnt pathway to induce neu-
rogenesis in the adult hippocampus (Lie et al., 2005). Moreover,
transgenic mice overexpressing β-catenin shows the same behav-
ior than lithium-treated animals suggesting that behavioral effects
of lithium may be mediated through the increment of β-catenin
(Gould et al., 2007). Additional studies are required to investigate
the involvement of Wnt in lithium-mediated neurogenesis and
behavior.
Recently, lithium has been also used to treat Ts65Dn mice, a
model of Down syndrome. It has been shown that these animals
exhibit several dysfunctions, such as synaptic failures and a sig-
niﬁcant reduced neurogenesis (Contestabile et al., 2013). Lithium,
through the activation of canonical Wnt pathway, recovered the
adult neurogenesis in these mice by stimulating the prolifer-
ation of neural precursor cells and increasing the number of
newborn cells turning into mature neurons in the DG (Chen
et al., 2000; Wexler et al., 2008; Contestabile et al., 2013). More
importantly, the consequence of this treatment is the improve-
ment of synaptic plasticity and cognitive functions dependent
on hippocampal plasticity (Contestabile et al., 2013). It has been
shown that Down syndrome has an excessive GABA inhibition
that could exert a negative effect on the neurogenesis during
embryonic and postnatal development, and on the excitatory neu-
rotransmission, altogether leading to performance impairment
(Kleschevnikov et al., 2004; Fernandez et al., 2007). Whether acti-
vation of Wnt pathway by lithium helps to partially restore the
imbalance in the neurotransmission in this model, is a matter
of further investigations. However, if so it suggests a possi-
ble therapeutic treatment to improve cognitive deﬁcits in this
disorder.
Wnt components such as GSK-3β have been also involved
in psychotic and hyperactivity behavior, also referred as
dopamine/serotonin-associated behaviors (Beaulieu et al., 2009).
Several studies have converged evidence for an involvement of
Akt and GSK-3 pathway in dopamine-related behavior and in the
mechanism of action of some psychoactive drugs (Beaulieu et al.,
2004; Beaulieu et al., 2005). It has been shown that overactivation
of dopamine receptor-2 (D2R) causes hyperactivity through up-
regulation of GSK-3β. The fact that the activation of Wnt pathway
causes the inactivation of GSK3β could provide a window where
to explore the potential usage of Wnt analogs as a treatment to
improve the physical manifestation of psychosis and hyperactivity
disorders.
Similar approaches directed to regulate GSK-3β can be found
in the serotonin-related behavior. One of the consequences of the
reduction of brain serotonin levels is the pronounced increment
of GSK-3β and several emotional abnormalities such as anxiety
and aggression in rodents (Beaulieu et al., 2008). Treating this ani-
mals with a speciﬁc GSK-3β inhibitor or breeding this animal with
an animal deﬁcient in GSK-3β, completely rescues the behavioral
abnormalities associated with the lack of serotonin (Lucki et al.,
2001; Weisstaub et al., 2006). This strongly suggests that GSK-3β
signaling mediate behavioral effects of serotonin. Moreover, it has
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been shown that the typical antipsychotic drug haloperidol and the
two atypicals risperidone and clozapine increase the protein level
of β-catenin, Dvl-3,Axin, GSK-3α/β, andWnt5a in prefrontal cor-
tex, and β-catenin, GSK-3α/β, and Dvl-3 in the dopamine centers
of the ventral midbrain (Alimohamad et al., 2005a,b; Sutton et al.,
2007). The antipsychotics drugs do not have any effect on Wnt1
and Wnt3a, on Fz, or JNK or c-JNK (Sutton et al., 2007). These
treatments cause an increment of β-catenin in the cytoplasm and
nucleus and involve TCF-mediated gene transcription, suggesting
that an abnormal expression of these proteins could underlie the
serotonin-mediated behavior.
Recently, important evidences have related depression to Wnt
signaling cascades (Duman and Voleti, 2012). It has been shown
that a decreased BDNF expression underlies the stress and depres-
sion and, conversely, the use of antidepressants causes enhanced
BDNF expression that could mediate the beneﬁcial effects in
the hippocampus and prefrontal cortex (Duman and Mon-
teggia, 2006; Krishnan and Nestler, 2008). In fact, BDNF is
sufﬁcient to produce antidepressant behavioral effect; however
deletion of BDNF is not enough to induce depression (Duman
and Monteggia, 2006; Schmidt and Duman, 2007). BDNF has
been recently described as a target of Wnt signaling (Yi et al.,
2012). On the other hand, it remains unresolved whether the
increase in BDNF levels is the result of Wnt signaling activa-
tion in these brain regions. However, other evidences could
sustain this possibility. Also, it has been reported that GSK3 is
required for the rapid antidepressant actions of ketamine (Beurel
et al., 2011). Ketamine increases GSK3 phosphorylation in the
mouse hippocampus and cerebral cortex (Beurel et al., 2011),
while microarray studies show that the use of antidepressants
differentially regulates the expression of Wnts, Fz receptors and
Dvl in hippocampus, as well as Tcf/Lef, demonstrating the rel-
evancy of the Wnt signaling components in the antidepressant
effects (Okamoto et al., 2010; Duman and Voleti, 2012). Still more
studies are required to elucidate the causes and potential bene-
ﬁcial effects of Wnt signaling on depression and related mood
disorders.
As we previously mentioned, it has been shown that β-catenin
regulates the expression of a novel group of genes in the thalamus
(Wisniewska et al., 2012). However, it is still not clear whether
variations in the level of β-catenin affect the expression of the
genes that encode voltage gated Ca2+ channels (VGCCs) and
neurotransmitter receptors, shaping neuronal excitability in vivo.
If so, then inappropriate activity of β-catenin might affect the
proper signal transmission in thalamocortical circuits. Thalam-
ocortical desynchronization underlies absence epilepsy (Hughes,
2009). Speciﬁcally, the T-type voltage-gated channel Cav3.1 has
been proposed to be implicated in absence seizures (Barclay
et al., 2001; Liu et al., 2007; Ernst et al., 2009). Moreover, anti-
convulsant drugs target voltage-gated channels (Errington et al.,
2005). In the opposite, schizophrenia has also been associated
with thalamic dysfunction (Harms et al., 2007; Smith et al., 2011;
Marenco et al., 2012), while a group of synaptic genes involved
in excitability have been found to be associated with the risk
of schizophrenia (Lips et al., 2012). These results suggest a pos-
sible role for β-catenin-dependent gene expression in thalamic
pathologies.
Wnt-RELATED DEVELOPMENTAL ABNORMALITIES IN
NEUROLOGICAL DISEASES
Literature has been recently populated with evidences indicat-
ing that changes during development could account for neu-
rological disease vulnerability in the adulthood (Penzes et al.,
2011; Penzes et al., 2013). Genetic mutations or environmen-
tal insults that perturb a normal developmental progression
could constitute an early signature of developmental disor-
ders. Nevertheless, disturbances that affect synapse morpho-
genesis and/or function during a speciﬁc developmental time
or in a particular brain region, also may determine the con-
sequent neuropathological symptom, such as neuronal circuit
alterations and ultimately cognitive and behavioral symptoms.
Mutations associated to initial cognitive disabilities may occur
in molecules that play an essential role in regulating brain
synapse formation and plasticity. Given the relevancy that Wnt
signaling pathways have in these processes, we hypothesized
that failures in establishing spines dendritic network could
be caused by failures in the Wnt signaling pathways during
development.
Some recent ﬁndings have provided important evidences to
support this idea. Individuals with autism, SZ and AD show alter-
ations in the density of dendritic spines in cortical pyramidal
cells (Penzes et al., 2011) and also exhibit functional and struc-
tural changes in the inhibitory circuits (Oblak et al., 2010, 2011;
Chattopadhyaya and Cristo, 2012). SZ patients show a profound
reduction in spines density in prefrontal cortex and in primary
auditory cortex, and also a reduction in the spines density and
size in the hippocampal CA3 region In fact, the disrupted in
schizophrenia (DISC1) gene is highly abundant in spines and it has
also been associated to other psychiatric disorders (Schumacher
et al., 2009). Indeed, DISC1 is known to interact with several well-
established regulators of dendritic spine morphogenesis (Millar
et al., 2003). Kalirin-7 via activation of a common Wnt pathway
downstream effector Rac1was found to directly regulate the effects
of DISC1 on the spines morphology (Hayashi-Takagi et al., 2010).
Kalirin- knockout mice remarkably show low spines density and
behavioral schizophrenia-related behaviors at an age in mice that
match to human adolescence, when the symptoms in humans
emerges.
CONCLUDING REMARKS
Emerging evidences suggest a role for Wnt pathway in synap-
tic maintenance and function of the adult brain. Activation of
Wnt pathway has an effect in both basal and evoked activity. As
we have discussed in this review, Wnt leads to rapid modiﬁca-
tion of the pre-synaptic compartment, regulating the clustering
of synaptic proteins and the recycling of synaptic vesicles, while
at the post-synaptic compartment Wnt modulates the assembly
of the post-synaptic apparatus and the dendritic spine morpho-
genesis. Recent evidences indicate that activation of Wnt pathway
modulates the efﬁcacy of the excitatory and inhibitory synaptic
transmission through divergent mechanisms. Moreover, activa-
tion of Wnt pathway enhances synaptic plasticity and the cognitive
function of the adult brain. In vivo studies have shown that
Wnt pathway is involved in both hippocampal- and amygdala-
dependent memory. Interestingly, these studies have evidenced
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that endogenous Wnt activity is required for the normal function-
ing of neuronal circuits and that the inhibition ofWnt pathway can
cause synaptic plasticity impairments and memory deﬁcits. More-
over, the inhibition of Wnt pathway also causes a reduction in the
basal spontaneous activity, which suggests that Wnt participates
in the establishment of mature neuronal networks. Deregulation
of Wnt pathway has been implicated in neurological pathologies,
including AD, SZ, and mood disorders. Particularly, Wnt activa-
tor may be therapeutically relevant in AD since it has been shown
activation of Wnt displays a neuroprotective effect and resolves
the synaptic and cognitive impairment in mouse model of AD. In
summary, the evidences discussed here show that Wnt pathway
plays a key role in the synaptic function of mature nervous system,
constituting a promising therapeutic target for the treatment of
certain neurological diseases.
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